China Pharma Holdings (CPHI) Assets Average (2011 - 2026)

China Pharma Holdings has reported Assets Average for 16 years, with the latest figure at $38.1 million in Q1 2026.

• For the quarter ending Q1 2026, Assets Average rose 161.62% year-over-year to $38.1 million; the trailing twelve-month figure through Mar 2026 stood at $38.1 million (up 161.62% YoY), and the FY2025 full-year result was $22.9 million, up 46.34% from the prior year.
• Assets Average for Q1 2026 stood at $38.1 million, up from $23.4 million in the prior quarter.
• The five-year high for Assets Average was $38.1 million in Q1 2026, with the low at $13.9 million in Q3 2024.
• Historically, Assets Average has averaged $18.0 million across 5 years, with a median of $16.3 million in 2024.
• Annual changes were most pronounced in 2023 — Assets Average declined 19.57% — and 2026, when it jumped 161.62%.
• China Pharma Holdings' Assets Average stood at $17.0 million in 2022, then retreated by 6.37% to $15.9 million in 2023, then decreased by 10.9% to $14.2 million in 2024, then surged by 65.08% to $23.4 million in 2025, then surged by 62.68% to $38.1 million in 2026.
• The last three Assets Average figures came in at $38.1 million (Q1 2026), $23.4 million (Q4 2025), and $14.8 million (Q3 2025), per Business Quant data.